AI Pharma: Artificial Intelligence in Drug Discovery and Development

AI Pharma: Artificial Intelligence in Drug Discovery and Development

by Daniel D. Lee

Narrated by Digital Voice Mike G

Unabridged — 5 hours, 22 minutes

AI Pharma: Artificial Intelligence in Drug Discovery and Development

AI Pharma: Artificial Intelligence in Drug Discovery and Development

by Daniel D. Lee

Narrated by Digital Voice Mike G

Unabridged — 5 hours, 22 minutes

Audiobook (Digital)

$5.00
FREE With a B&N Audiobooks Subscription | Cancel Anytime
$0.00

Free with a B&N Audiobooks Subscription | Cancel Anytime

START FREE TRIAL

Already Subscribed? 

Sign in to Your BN.com Account


Listen on the free Barnes & Noble NOOK app


Related collections and offers

FREE

with a B&N Audiobooks Subscription

Or Pay $5.00

Overview

This audiobook is narrated by a digital voice.


"AI Pharma: Artificial Intelligence in Drug Discovery and Development" is a comprehensive exploration of how artificial intelligence is reshaping the pharmaceutical industry. It reveals how machine learning, deep learning, and other advanced technologies are revolutionizing drug discovery and development. The book meticulously charts the evolution of AI's role, starting from the surge in data collection and processing to the latest breakthroughs in predictive modeling.

It unveils AI's transformative impact on research and development, delving into how AI tools streamline target identification, molecule generation, and clinical trials, leading to faster, more accurate results. Key industry experts share insights on the challenges of navigating the vast amount of data produced, stressing the importance of data cleaning, curation, and ethical considerations in collection.*

Case studies highlight how startups and leading companies use AI algorithms for deep learning in drug development, identifying disease targets and generating new compounds with unprecedented precision. The book emphasizes practical applications, like predictive models for toxicity and safety in preclinical trials and patient recruitment optimization in clinical trials.*

Additionally, it tackles the intersection of AI with emerging technologies like the Internet of Medical Things (IoMT) and blockchain, showcasing how these complement AI in securing data and enhancing pharmaceutical supply chains. Readers will gain a deep understanding of the regulatory landscape, exploring FDA guidelines and global regulations that shape AI adoption.


Product Details

BN ID: 2940192658314
Publisher: SkyCuration
Publication date: 05/13/2024
Edition description: Unabridged
From the B&N Reads Blog

Customer Reviews